{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:32:39Z","timestamp":1792740759172,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-024-00653-1","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T03:02:31Z","timestamp":1730170951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["At-home wearable-based monitoring predicts clinical measures and biological biomarkers of disease severity in Friedreich\u2019s Ataxia"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9441-683X","authenticated-orcid":false,"given":"Ram Kinker","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adonay S.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Enriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria R.","family":"Profeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"653_CR1","doi-asserted-by":"crossref","unstructured":"Lynch, D. R., Schadt, K., Kichula, E., McCormack, S. & Lin, K. Y. Friedreich ataxia: multidisciplinary clinical care. J. Multidiscip. Healthcare 14, 1645\u20131658 (2021).","DOI":"10.2147\/JMDH.S292945"},{"key":"653_CR2","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/14737175.2017.1356721","volume":"17","author":"C Strawser","year":"2017","unstructured":"Strawser, C. et al. Pharmacological therapeutics in Friedreich ataxia: the present state. Expert Rev. Neurotherapeutics 17, 895\u2013907 (2017).","journal-title":"Expert Rev. Neurotherapeutics"},{"key":"653_CR3","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1089\/hum.2020.264","volume":"31","author":"IH Harding","year":"2020","unstructured":"Harding, I. H., Lynch, D. R., Koeppen, A. H. & Pandolfo, M. Central nervous system therapeutic targets in Friedreich ataxia. Hum. Gene Ther. 31, 1226\u20131236 (2020).","journal-title":"Hum. Gene Ther."},{"key":"653_CR4","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/01.wnl.0000218155.46739.90","volume":"66","author":"DR Lynch","year":"2006","unstructured":"Lynch, D. R. et al. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology 66, 1711\u20131716 (2006).","journal-title":"Neurology"},{"key":"653_CR5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/mds.29286","volume":"38","author":"DR Lynch","year":"2023","unstructured":"Lynch, D. R. et al. Efficacy of Omaveloxolone in Friedreich\u2019s Ataxia: Delayed\u2010Start Analysis of the MOXIe Extension. Mov. Disord. 38, 313\u2013320 (2023).","journal-title":"Mov. Disord."},{"key":"653_CR6","doi-asserted-by":"crossref","unstructured":"Rummey, C. et al. Harmonizing results of ataxia rating scales: mFARS, ARA, and ICARS. Ann. Clin. Transl. Neurol. 9, 2041\u20132046 (2022).","DOI":"10.1002\/acn3.51686"},{"key":"653_CR7","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1212\/WNL.0000000000200913","volume":"99","author":"C Rummey","year":"2022","unstructured":"Rummey, C. et al. Natural History of Friedreich Ataxia: heterogeneity of neurologic progression and consequences for clinical trial design. Neurology 99, e1499\u2013e1510 (2022).","journal-title":"Neurology"},{"key":"653_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.25934","volume":"89","author":"DR Lynch","year":"2021","unstructured":"Lynch, D. R. et al. Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study). Ann. Neurol. 89, 212\u2013225 (2021).","journal-title":"Ann. Neurol."},{"key":"653_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/acn3.51118","volume":"7","author":"C Rummey","year":"2020","unstructured":"Rummey, C. et al. Test\u2013retest reliability of the Friedreich\u2019s ataxia rating scale. Ann. Cli. Transl. Neurol. 7, 1708\u20131712 (2020).","journal-title":"Ann. Cli. Transl. Neurol."},{"key":"653_CR10","doi-asserted-by":"crossref","unstructured":"Rummey, C. et al. Psychometric properties of the Friedreich ataxia rating scale. Neurol. Genet. 5, 371 (2019).","DOI":"10.1212\/NXG.0000000000000371"},{"key":"653_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/jimd.12285","volume":"44","author":"MY Qureshi","year":"2021","unstructured":"Qureshi, M. Y. et al. Safety and efficacy of (+)\u2010epicatechin in subjects with Friedreich\u2019s ataxia: A phase II, open\u2010label, prospective study. J. Inherit. Metab. Dis. 44, 502\u2013514 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"key":"653_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/acn3.660","volume":"6","author":"DR Lynch","year":"2019","unstructured":"Lynch, D. R. et al. Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia. Ann. Clin. Transl. Neurol. 6, 15\u201326 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"653_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mds.28313","volume":"36","author":"S Perez\u2010Lloret","year":"2021","unstructured":"Perez\u2010Lloret, S. et al. Assessment of ataxia rating scales and cerebellar functional tests: critique and recommendations. Mov. Disord. 36, 283\u2013297 (2021).","journal-title":"Mov. Disord."},{"key":"653_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acn3.731","volume":"6","author":"DR Lynch","year":"2019","unstructured":"Lynch, D. R. et al. Randomized, double\u2010blind, placebo\u2010controlled study of interferon\u2010\u03b3 1b in Friedreich Ataxia. Ann. Clin. Transl. Neurol. 6, 546\u2013553 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"653_CR15","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/mds.22912","volume":"25","author":"LS Friedman","year":"2010","unstructured":"Friedman, L. S. et al. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov. Disord. 25, 426\u2013432 (2010).","journal-title":"Mov. Disord."},{"key":"653_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gaitpost.2003.07.005","volume":"20","author":"A Paraschiv-Ionescu","year":"2004","unstructured":"Paraschiv-Ionescu, A., Buchser, E., Rutschmann, B., Najafi, B. & Aminian, K. Ambulatory system for the quantitative and qualitative analysis of gait and posture in chronic pain patients treated with spinal cord stimulation. Gait Posture 20, 113\u2013125 (2004).","journal-title":"Gait Posture"},{"key":"653_CR17","doi-asserted-by":"publisher","unstructured":"Mishra, R. K. et al. Decrease in Mobility during the COVID-19 Pandemic and its association with increase in depression among older adults: a longitudinal remote mobility monitoring using a wearable sensor. Sensors 21 https:\/\/doi.org\/10.3390\/s21093090 (2021).","DOI":"10.3390\/s21093090"},{"key":"653_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1109\/JTEHM.2018.2829208","volume":"6","author":"SI Lee","year":"2018","unstructured":"Lee, S. I. et al. Enabling stroke rehabilitation in home and community settings: a wearable sensor-based approach for upper-limb motor training. IEEE J. Transl. Eng. Health Med. 6, 1\u201311 (2018).","journal-title":"IEEE J. Transl. Eng. Health Med."},{"key":"653_CR19","first-page":"2023","volume":"ume 14","author":"SN Adonay","year":"2023","unstructured":"Adonay, S. N., \u0130lkay, Y. P., Mishra, R. K., Paolo, B. & Vaziri, A. A deep learning wearable-based solution for continuous at-home monitoring of upper limb goal-directed movements. Front. Neurol. Sect. Mov. Disord. ume 14, 2023 (2023).","journal-title":"Front. Neurol. Sect. Mov. Disord."},{"key":"653_CR20","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1177\/193229681300700507","volume":"7","author":"B Najafi","year":"2013","unstructured":"Najafi, B., Armstrong, D. G. & Mohler, J. Novel wearable technology for assessing spontaneous daily physical activity and risk of falling in older adults with diabetes. J. Diab. Sci. Technol. 7, 1147\u20131160 (2013).","journal-title":"J. Diab. Sci. Technol."},{"key":"653_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K. & Li, M. Y. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropr. Med. 15, 155\u2013163 (2016).","journal-title":"J. Chiropr. Med."},{"key":"653_CR22","doi-asserted-by":"crossref","unstructured":"Jovi\u0107, A., Brki\u0107, K. & Bogunovi\u0107, N. A review of feature selection methods with applications. In 38th international convention on information and communication technology, electronics and microelectronics (MIPRO). 1200\u20131205 (IEEE, 2015).","DOI":"10.1109\/MIPRO.2015.7160458"},{"key":"653_CR23","doi-asserted-by":"crossref","unstructured":"Hastie, T., Tibshirani, R., Friedman, J. H. & Friedman, J. H. The elements of statistical learning: data mining, inference, and prediction (Springer, 2009).","DOI":"10.1007\/978-0-387-84858-7"},{"key":"653_CR24","doi-asserted-by":"crossref","unstructured":"Ilg, W. et al. Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers. Cerebellum 23, 1566\u20131592 (2023).","DOI":"10.1007\/s12311-023-01625-2"},{"key":"653_CR25","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/acn3.51438","volume":"8","author":"A Mueller","year":"2021","unstructured":"Mueller, A. et al. Digital endpoints for self\u2010administered home\u2010based functional assessment in pediatric Friedreich\u2019s ataxia. Ann. Clin. Transl. Neurol. 8, 1845\u20131856 (2021).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"653_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","volume":"303","author":"AH Koeppen","year":"2011","unstructured":"Koeppen, A. H. Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 303, 1\u201312 (2011).","journal-title":"J. Neurol. Sci."},{"key":"653_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41591-022-02159-6","volume":"29","author":"B Kadirvelu","year":"2023","unstructured":"Kadirvelu, B. et al. A wearable motion capture suit and machine learning predict disease progression in Friedreich\u2019s ataxia. Nat. Med. 29, 86\u201394 (2023).","journal-title":"Nat. Med."},{"key":"653_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65303-7","volume":"10","author":"B Kashyap","year":"2020","unstructured":"Kashyap, B. et al. Objective assessment of cerebellar ataxia: a comprehensive and refined approach. Sci. Rep. 10, 9493 (2020).","journal-title":"Sci. Rep."},{"key":"653_CR29","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.3390\/s22207993","volume":"22","author":"R Mohammadi-Ghazi","year":"2022","unstructured":"Mohammadi-Ghazi, R. et al. Objective assessment of upper-extremity motor functions in spinocerebellar ataxia using wearable sensors. Sensors 22, 7993 (2022).","journal-title":"Sensors"},{"key":"653_CR30","doi-asserted-by":"crossref","unstructured":"Zhou, H. et al. Assessment of gait and balance impairment in people with spinocerebellar ataxia using wearable sensors. Neurol. Sci. 43, 2589\u20132599 (2022).","DOI":"10.1007\/s10072-021-05657-6"},{"key":"653_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1342965","volume":"15","author":"M Fichera","year":"2024","unstructured":"Fichera, M. et al. Accelerometer-based measures in Friedreich ataxia: a longitudinal study on real-life activity. Front Pharm. 15, 1342965 (2024).","journal-title":"Front Pharm."},{"key":"653_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1159\/000460292","volume":"63","author":"S Parvaneh","year":"2017","unstructured":"Parvaneh, S., Mohler, J., Toosizadeh, N., Grewal, G. S. & Najafi, B. Postural transitions during activities of daily living could identify frailty status: application of wearable technology to identify frailty during unsupervised condition. Gerontology 63, 479\u2013487 (2017).","journal-title":"Gerontology"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00653-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:04:56Z","timestamp":1730214296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00653-1","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"At the time of performing the study, R.K.M., A.S.N., A.E., and A.V. were employees of BioSensics LLC, the developer and manufacturer of the wearable sensors used in this study. D.R.L. receives funding from the National Institute of Health, Friedrich\u2019s Ataxia Research Alliance (FARA), Reata Pharmaceuticals Inc., PTC Therapeutics Inc., and Design Therapeutics. V.R.P. and M.W. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}